HCM
AVNS icon

Highbridge Capital Management’s Avanos Medical AVNS Stock Holding History

Highbridge Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-31,900
Closed -$917K – 1381
2016
Q1 		$917K Buy
31,900
+10,800
+51% +$288K 0.02% 766
2015
Q4 		$704K Buy
+21,100
New +$656K 0.01% 879

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Highbridge Capital Management's AVNS Position: Q2 2017 in Review

Highbridge Capital Management sold out of Avanos Medical (AVNS) in Q2 2017, closing a stake of 8,894 shares — an estimated $339K sold.

Highbridge Capital Management first reported a position in AVNS in Q1 2015 and held it in 5 quarters. The position peaked at $7.41M in Q2 2015. 328 funds tracked by Wall St. Rank hold AVNS as of Q2 2017.

  • Highbridge Capital Management reported no remaining Avanos Medical position as of Q2 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 8,894 Avanos Medical shares in Q2 2017, an estimated $339K.
  • Highbridge Capital Management first reported a position in Avanos Medical in Q1 2015 and held it in 5 quarters.
  • Highbridge Capital Management's Avanos Medical position peaked at $7.41M in Q2 2015.
  • 328 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2017.

Based on Highbridge Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.